Shlomo Noy active positions
Companies | Position | Start | End |
---|---|---|---|
Innovalve Bio Medical Ltd.
Innovalve Bio Medical Ltd. Medical SpecialtiesHealth Technology Innovalve Bio Medical Ltd. is an Israeli medical device company that specializes in developing catheter-delivered heart valve therapies. Innovalve Bio Medical was founded in 2017 by Boris Orlov and Ehud Raanani, and is currently based in Ramat Gan, IL. The company aims to address the prevalent and progressive disease of Mitral Regurgitation (MR), which affects nearly 1 in 10 people aged 75 and older. MR is a progressive disease that can lead to advanced stages of MR, heart failure, and other complications. Eyal Baror has been the CEO of the company since 2020. | Director/Board Member | 2018-08-08 | - |
Career history of Shlomo Noy
Former positions of Shlomo Noy
Companies | Position | Start | End |
---|---|---|---|
Medx Xelerator LP
Medx Xelerator LP Medical SpecialtiesHealth Technology Medx Xelerator LP provides medical devices incubator. The company is headquartered in Or Yehuda, Israel. | Director/Board Member | - | - |
Statistics
International
Israel | 3 |
Operational
Director/Board Member | 2 |
Sectoral
Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Medx Xelerator LP
Medx Xelerator LP Medical SpecialtiesHealth Technology Medx Xelerator LP provides medical devices incubator. The company is headquartered in Or Yehuda, Israel. | Health Technology |
Innovalve Bio Medical Ltd.
Innovalve Bio Medical Ltd. Medical SpecialtiesHealth Technology Innovalve Bio Medical Ltd. is an Israeli medical device company that specializes in developing catheter-delivered heart valve therapies. Innovalve Bio Medical was founded in 2017 by Boris Orlov and Ehud Raanani, and is currently based in Ramat Gan, IL. The company aims to address the prevalent and progressive disease of Mitral Regurgitation (MR), which affects nearly 1 in 10 people aged 75 and older. MR is a progressive disease that can lead to advanced stages of MR, heart failure, and other complications. Eyal Baror has been the CEO of the company since 2020. | Health Technology |
- Stock Market
- Insiders
- Shlomo Noy
- Experience